Endowed Awards

The Antonio M. Gotto, Jr. Prize in Atherosclerosis Research was awarded to Dr. Daniel J. Rader, an investigator from the Perelman School of Medicine, during the XVIII International Symposium on Atherosclerosis held on June 9-12 in Toronto, Canada.
The triennial Prize, endowed by Weill Cornell Medicine and the International Atherosclerosis Society in honor of Dr. Gotto, Dean Emeritus of Weill Cornell Medicine, recognizes outstanding scientific, medical or organizational advancement in our ability to understand the causes and the development of atherosclerosis.
The award was made in recognition of Daniel’s as a leading translational scientist who has made major contributions to our understanding of lipoprotein metabolism. His work is distinguished by its clear and direct impact on the development of new therapeutic strategies to prevent coronary heart disease (CHD). Rader discovered endothelial lipase and elucidated its role in metabolism of high density lipoproteins (HDL). He developed novel methods to trace macrophage-specific RCT in mice and assess HDL function in humans. Rader also singlehandedly championed microsomal triglyceride transfer protein (MTP) inhibitors for treatment of severe hypercholesterolemia. Rader has provided important new insights into the mechanisms by which common sequence variations discovered in genome-wide association studies alter plasma lipoprotein levels. His work spans the full spectrum of translational research, extending from basic laboratory science to the development and testing of new therapeutic agents in humans. His work has had a major impact on current strategies to prevent and treat CHD.


In relation to the Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region project, I am pleased to inform you that after the selection from the Review Committee, I am honored to announce the winners of these prestigious Fellowships:

This high-level initiative has been made possible thanks to a generous donation kindly offered by Dr. Wael Abdulrahman Al Mahmeed (Abu Dhabi, UAE).

Congratulations to the winners and best wishes to our young colleagues for successful research outcomes from the entire IAS family !

The International Atherosclerosis Society is pleased to inform that the 2nd Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region & Africa project is also open to Africa. The entire IAS Board is honored and grateful to Dr. Wael Abdulrahman Al Mahmeed (Abu Dhabi, UAE) for making this high-level initiative possible.

The 2nd Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region & Africa is a competitive research funding opportunity aimed at advancing clinical and basic research in atherosclerosis and related cardio-metabolic-cerebrovascular diseases in the MENA Region & Africa, as well as promoting partnerships among researchers from recognized MENA & Africa Universities and healthcare institutions.

Aim of the 2nd Wael Al-Mahmeed & IAS Research Training Grants and Fellowships program is to help young researchers to improve skills and knowledge in the field of atherosclerosis and related cardio-metabolic-cerebrovascular diseases in the MENA Region & Africa by:

  • Acquiring new research techniques
  • Implementing new clinical techniques
  • Initiating innovative programs in atherosclerosis and related cardio-metabolic-cerebrovascular diseases
  • Accepted post-doctoral training in a lipid-intense research laboratory
  • Implementing ongoing research in the applicant’s laboratory.

The 2nd Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region & Africa will award up to three $10,000 grants for a maximum period of 6 months. The final granted amount will be calculated pro rata, according to the length of the certified training period or the duration of the research.

Application submission will open on Friday, November 15, 2019. For further information about the application on line please link to http://grants.athero.org/MENARegion/

The deadline for submission will be Monday, January 30, 2020.

The first Prize will be presented at the 19th International Symposium on Atherosclerosis (ISA2021) in Kyoto (Japan) in October 2021. The Prize is sponsored by the R3i Foundation and the International Atherosclerosis Society.